Found 10 matching trials
MK0767 and Sulfonylurea Combination Study (0767-027)
PHASE3This study will assess MK0767's ability vs. placebo to control blood glucos...
Location
Multiple Locations
Dyslipidemia in Type 2 Diabetes (0767-034)
PHASE3The purpose of the study is to compare the lipid-altering effects of MK0767...
Location
Multiple Locations
MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
PHASE3A study to evaluate the cardiac and metabolic effects of MK0767 in patients...
Location
Multiple Locations
MK0767 and Metformin Combination Study (0767-028)
PHASE3A study to test the effects of MK0767 when added to Metformin in patients w...
Location
Multiple Locations
MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)
PHASE3This study will look to see if MK0767 works better than placebo in controll...
Location
Multiple Locations
MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)
PHASE2This is a clinical trial in patients with Metabolic Syndrome and Dyslipidem...
Location
Multiple Locations
MK0767 in Type 2 Diabetes (0767-012)
PHASE2This is a clinical trial in patients with Type 2 Diabetes to test the safet...
Location
Multiple Locations
Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)
PHASE3The purpose of this study is to compare how MK0767 and metformin and sulfon...
Location
Multiple Locations
Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)
PHASE3The purpose of the study is to assess how MK0767, compared to Metformin, pe...
Location
Multiple Locations
Study A - MK0767 Monotherapy Study
PHASE3The purpose of this study is to test if MK0767 lowers blood glucose after 2...
Location
Multiple Locations